Table 3

- Relationship between anticoagulant type and the effectiveness of prothrombin complex concentrate and the dose.

Types of anticoagulantsEffective n (%) (M±SD)Ineffective n (%) (M±SD)Total (n,%)P-value
VKA PCC dose14 (88)
2196±573.3
2 (12)
1000±707.1
16 (100)0.02
Dabigatran PCC dose1 (50)
2000
1 (50)
2500
2 (100) 
Rivaroxaban PCC dose4 (100)
2156±986.2
04 (100) 
PCC: prothrombin complex concentrate